Now Is A Suitable Moment For A Long-Term Purchase Of Bristol-Myers Squibb Co. (NYSE: BMY)
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Bristol-Myers Squibb Co. (BMY) Volatility Spurs A Quest For Clarity
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 138 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Bristol-Myers Squibb Co. (NYSE: BMY): The Best-Of-Breed For Investing?
Insiders at the company have transacted a total of 140 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 86 of these insider trades were purchases, accounting for 710,591 shares. Insider sales of the common stock occurred on 54 occasions, with total insider shares sold totaling […]
Bristol-Myers Squibb Co. (NYSE: BMY) – Suitable For Long Term Buy?
BlackRock Fund Advisors recently announced the acquisition of new stake in Bristol-Myers Squibb Co. (NYSE:BMY). The institutional investor has increased its shareholding in the Healthcare company by 0.27% to 110.79 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 5.45% valued currently at $5.68 billion. In addition, Capital […]
Value Hunters: Look To Bristol-Myers Squibb Co. (BMY)
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 140 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 86 of these insider trades were purchases, […]
Gains May Be On The Menu For Bristol-Myers Squibb Co. (NYSE: BMY)
BlackRock Fund Advisors recently announced the acquisition of new stake in Bristol-Myers Squibb Co. (NYSE:BMY). The institutional investor has increased its shareholding in the Healthcare company by 0.27% to 110.79 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 5.45% valued currently at $5.68 billion. In addition, Capital […]
Is Bristol-Myers Squibb Co. (NYSE: BMY) Back In The Buying Zone?
BlackRock Fund Advisors recently announced the acquisition of new stake in Bristol-Myers Squibb Co. (NYSE:BMY). The institutional investor has increased its shareholding in the Healthcare company by 0.27% to 110.79 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 5.45% valued currently at $5.47 billion. In addition, Capital […]
Bristol-Myers Squibb Co. (BMY) Testing Investors’ Patience Right Now
BlackRock Fund Advisors recently announced the acquisition of new stake in Bristol-Myers Squibb Co. (NYSE:BMY). The institutional investor has increased its shareholding in the Healthcare company by 0.27% to 110.79 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 5.45% valued currently at $5.47 billion. In addition, Capital […]
Reassessing The Changing Outlook For Bristol-Myers Squibb Co. (BMY)
BlackRock Fund Advisors recently announced the acquisition of new stake in Bristol-Myers Squibb Co. (NYSE:BMY). The institutional investor has increased its shareholding in the Healthcare company by 0.27% to 110.79 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 5.45% valued currently at $5.47 billion. In addition, Capital […]
Bristol-Myers Squibb Co. (BMY) Testing Investors’ Patience Right Now
With over 44.12 million Bristol-Myers Squibb Co. (BMY) shares trading Friday and a closing price of $50.89 on the day, the dollar volume was approximately $2.25 billion. The shares have shown a negative half year performance of -23.08% and its price on 12/15/23 lost nearly -1.13%. Currently, there are 2.10B common shares owned by the […]
